Tuberculosis vaccine: How a pharma giant prioritised billions in profit over developing the shot

Tuberculosis remains a ‘poor’ disease that mostly afflicts those living in developing countries.

Related Keywords

South Africa ,Chile ,Philadelphia ,Pennsylvania ,United States ,National Institutes Of Health ,Maryland ,Netherlands ,United Kingdom ,Buenos Aires ,Distrito Federal ,Argentina ,Brazil ,Rockville ,Montana ,Thailand ,Australia ,Chilean ,America ,South African ,Thomas Scriba ,Tom Evans ,Wolfgang Leitner ,Mike Frick ,Neil Martinson ,Paul Sagan ,Steven Reed ,Julio Croda ,Luc Debruyne ,Jeremy Farrar ,Smithkline Beckman ,Glenda Gray ,Emma Walmsley ,Wikimedia Commons ,Carl Alving ,Thomas Breuer ,Treatment Action Group ,Tb Vaccine Accelerator Council ,Tuberculosis Research Section ,Reuters ,Walter Reed Army Institute Of Research ,Drug Administration ,National Institute Of Allergy ,Melinda Gates Foundation ,National Institute Of Health ,Laboratory Of Clinical Immunology Microbiology ,Us Army ,Department Of Veterans Affairs ,Gates Foundation ,Melinda Gates Medical Research Institute ,Cornell University ,Wellcome ,World Health Organization ,Big Pharma ,Melinda Gates Medical Research ,Walter Reed Army Institute ,Veterans Affairs ,National Institutes ,Clinical Immunology ,Michel De Wilde ,National Institute ,World Health ,Wellcome Trust ,South America ,Eastern Europe ,Accelerator Council ,Walter Reed Army ,Infectious Diseases ,Treatment Action ,Health ,Sk Tb Vaccine ,S Therea Tb Vaccine ,S Therea Tb Vaccine For Adults ,Roblems With Big Pharma ,Hat 39s Wrong With Big Pharma ,Iggest Problems With Big Pharma ,B Vaccine History ,Isease Disparities ,